Case Report: First-Line Immunotherapy for Esophageal Squamous Carcinoma Combined With Hypopharyngeal Squamous Carcinoma Yields Sustained Survival Benefit

Esophageal cancer, as one of the most common malignant tumors in the upper gastrointestinal tract, is highly invasive, with poor prognosis and low 5-year survival rate. Hypopharyngeal cancer has a low incidence among head and neck malignant tumors, but its prognosis is poor and it is prone to recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Liu, Xiangliang, Song, Wei, Lu, Jin, Yin, Na, Ye, Xiaojun, Chen, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311332/
https://www.ncbi.nlm.nih.gov/pubmed/35898511
http://dx.doi.org/10.3389/fimmu.2022.907705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311332/
https://www.ncbi.nlm.nih.gov/pubmed/35898511
http://dx.doi.org/10.3389/fimmu.2022.907705

Ejemplares similares